QMG Now Offers Inspire Upper Airway Stimulation Therapy for Obstructive Sleep Apnea

December 16, 2019

QUIN­CY, IL – Quin­cy Med­ical Group (QMG) is now offer­ing Inspire Upper Air­way Stim­u­la­tion (UAS) ther­a­py, a break­through obstruc­tive sleep apnea (OSA) treat­ment option for those who can­not use Con­tin­u­ous Pos­i­tive Air­way Pres­sure (CPAP) ther­a­py. QMG is the first in the local area to offer this therapy.

OSA affects 18 mil­lion Amer­i­cans. When left untreat­ed, OSA can cause vehi­cle and work­place acci­dents, wors­en­ing mood and mem­o­ry, stroke, heart attack, and even death. It occurs when the air­way col­laps­es dur­ing sleep and blocks the flow of oxy­gen to the brain. The brain sens­es a lack of oxy­gen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats through­out the night and caus­es poor, dis­rup­tive sleep.

Inspire ther­a­py works inside the body with a patient’s nat­ur­al breath­ing process to treat sleep apnea. Mild stim­u­la­tion keeps the air­way open dur­ing sleep, allow­ing oxy­gen to flow nat­u­ral­ly. The patient uses a small hand­held remote to turn Inspire on before bed and off when they wake up.

The safe­ty and effi­ca­cy of Inspire ther­a­py were mea­sured dur­ing the STAR clin­i­cal tri­al. One-year STAR tri­al results were pub­lished in the Jan­u­ary 9, 2014 edi­tion of the New Eng­land Jour­nal of Med­i­cine, show­ing patients using Inspire ther­a­py had sig­nif­i­cant reduc­tions in sleep apnea events and sig­nif­i­cant improve­ments in qual­i­ty of life mea­sures. These sig­nif­i­cant reduc­tions and improve­ments were sus­tained over a five-year fol­low-up period.

In our prac­tice, we see many patients with sleep apnea who have dif­fi­cul­ty tol­er­at­ing CPAP,” said Dr. Abra­ham Sheffield, Ear, Nose, and Throat physi­cian with QMG. Inspire ther­a­py rep­re­sents a sig­nif­i­cant advance­ment in treat­ing sleep apnea. It is clin­i­cal­ly proven to reduce sleep apnea events and also has a high lev­el of patient sat­is­fac­tion and ther­a­py adher­ence. We are very excit­ed to offer this new ther­a­py to sleep apnea patients who strug­gle with using CPAP.”

To set up an appoint­ment for an eval­u­a­tion, please con­tact your pri­ma­ry care provider for a refer­ral, call the QMG Sleep Cen­ter 217−277−4056, or vis­it quin​cymed​group​.com/​i​n​s​p​i​r​e​s​leep/.